FDA OKs Hermes AI-Powered, Digital-Twin Knee Replacement Planning Tool

Vent Creativity, a digital-twinning based medical software company, has earned U.S. Food and Drug Administration (FDA) clearance for its new Hermes Knee artificial intelligence (AI)-based software solution.

Hermes Knee leverages deep learning to generate surgical plans for mechanical, kinematic, and anatomical alignment techniques for total and partial knee arthroplasty (TKA/PKA) surgeries. It’s built on the company’s Minerva platform and can analyze procedures for research applications in other indications.

Users can interact with bone structures using the system through intensity representations in point cloud format so surgeons and radiologists can assess variations in human phenotypes and arthritic states. They can then view resulting cut planes, screw trajectories, and other operations pre-op to assess and compare patients to previous cases.

Hermes Knee is also cloud based through secure protocols.

Surgeons can modify resulting plans and annotate for any areas of concern. Reports can then be generated for documentation for outcome studies, possible reimbursement, or other uses by accredited medical professionals.

“We are a company of industry professionals who have worked on every aspect of the orthopedic and medical technology and have identified patient specific planning with digital-twin informed technologies to be the missing link in the reported outcomes,” commented Vent Creativity CEO Gilly Yildrim. “Our unique approach to everything in healthcare is our strength as we have shown a free and fast-moving path to patents, publications, and regulatory submissions. We intend to prioritize research and development while sharing appropriate data with our partners for mutual growth of the healthcare sector desperate for collaborative instead of competitive growth for all.”